Skip to content

Clinical trials

Phase 3 Stroke trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Philippines Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20061
20072
20082
20091
20101
20122
20131
20161
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan2
AstraZeneca2
Sanofi2
Bayer1
Boehringer Ingelheim1
CHIMES Society1
Daiichi Sankyo1
Eli Lilly and Company1
H. Lundbeck A/S1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke16
Atrial Fibrillation5
Myocardial Infarction5
Cardiovascular Diseases3
Heart Diseases3
Acute Coronary Syndrome2
Cerebral Palsy2
Coronary Artery Disease2
Embolism2
Muscle Spasticity2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.